The macrophage: Switches from a passenger to a driver during anticancer therapy.
Journal articles
- Journal Article
Wang, T; Feldman, GM; Herlyn, M; Kaufman, RE
Published in: Oncoimmunology
December 2015
We have recently discovered that BRAF inhibitors induce potent macrophage responses that confer melanoma resistance to therapy. Our studies lay a foundation for the hypothesis that macrophages switch their role from a passenger to a driver for tumor survival during therapeutic treatment, suggesting that agents that target macrophages can be an important component of "cocktail" anticancer therapy.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Oncoimmunology
DOI
ISSN
2162-4011
Publication Date
December 2015
Volume
4
Issue
12
Start / End Page
e1052929
Location
United States
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, T., Feldman, G. M., Herlyn, M., & Kaufman, R. E. (2015). The macrophage: Switches from a passenger to a driver during anticancer therapy. Oncoimmunology, 4(12), e1052929. https://doi.org/10.1080/2162402X.2015.1052929
Wang, Tao, Gerald M. Feldman, Meenhard Herlyn, and Russel E. Kaufman. “The macrophage: Switches from a passenger to a driver during anticancer therapy.” Oncoimmunology 4, no. 12 (December 2015): e1052929. https://doi.org/10.1080/2162402X.2015.1052929.
Wang T, Feldman GM, Herlyn M, Kaufman RE. The macrophage: Switches from a passenger to a driver during anticancer therapy. Oncoimmunology. 2015 Dec;4(12):e1052929.
Wang, Tao, et al. “The macrophage: Switches from a passenger to a driver during anticancer therapy.” Oncoimmunology, vol. 4, no. 12, Dec. 2015, p. e1052929. Pubmed, doi:10.1080/2162402X.2015.1052929.
Wang T, Feldman GM, Herlyn M, Kaufman RE. The macrophage: Switches from a passenger to a driver during anticancer therapy. Oncoimmunology. 2015 Dec;4(12):e1052929.
Published In
Oncoimmunology
DOI
ISSN
2162-4011
Publication Date
December 2015
Volume
4
Issue
12
Start / End Page
e1052929
Location
United States
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology